Keywords
Last Name
Institution

Susan M. Lerner

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentSurgery
Address5 East 98th Street
12th Floor
New York NY 10029
Phone212-659-8086
Fax646-537-9295
    Other Positions
    TitleASSISTANT PROFESSOR
    InstitutionMount Sinai
    DepartmentMedical Education


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, Xiao L, Hu J, Reuben JM, Calin S, You MJ, Manning JT, Wierda WG, Estrov Z, O'Brien S, Kipps TJ, Keating MJ, Kay NE, Calin GA. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12; 122(11):1891-9.
      View in: PubMed
    2. Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. J Mol Diagn. 2013 Mar; 15(2):196-209.
      View in: PubMed
    3. Lerner SM. Hepatitis C and renal transplantation. Mt Sinai J Med. 2012 May-Jun; 79(3):342-50.
      View in: PubMed
    4. Nair V, Sawinski D, Akalin E, Friedlander R, Ebcioglu Z, Sehgal V, Dinavahi R, Khaim R, Ames S, Lerner S, Murphy B, Bromberg JS, Heeger PS, Schröppel B. Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates. Clin Transplant. 2012 May-Jun; 26(3):E261-8.
      View in: PubMed
    5. Richter A, Lerner SM, Schröppel B. Curing diabetes with transplantation? Mt Sinai J Med. 2012 Mar-Apr; 79(2):267-75.
      View in: PubMed
    6. Garg R, Wierda W, Ferrajoli A, Abruzzo L, Pierce S, Lerner S, Keating M, O'Brien S. The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia. Cancer. 2012 Jul 15; 118(14):3531-7.
      View in: PubMed
    7. Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Garcia-Manero G, Cortes J, Thomas D, Koller CA, Burger JA, Lerner S, Schlette E, Abruzzo L, Kantarjian HM, Keating MJ. Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia. J Clin Oncol. 2011 Nov 1; 29(31):4088-95.
      View in: PubMed
    8. Dinavahi R, George A, Tretin A, Akalin E, Ames S, Bromberg JS, Deboccardo G, Dipaola N, Lerner SM, Mehrotra A, Murphy BT, Nadasdy T, Paz-Artal E, Salomon DR, Schröppel B, Sehgal V, Sachidanandam R, Heeger PS. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol. 2011 Jun; 22(6):1168-78.
      View in: PubMed
    9. Richter A, Lerner S, Schröppel B. Current state of combined kidney and pancreas transplantation. Blood Purif. 2011; 31(1-3):96-101.
      View in: PubMed
    10. Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S, LaPushin R, Xiao L, Huang X, Werner L, Neuberg D, Kantarjian H, O'Brien S, Wierda WG, Keating MJ, Rosenwald A, Burger JA. CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2011 Feb 3; 117(5):1662-9.
      View in: PubMed
    11. Lief MH, Caplivski D, Bottone EJ, Lerner S, Vidal C, Huprikar S. Exophiala jeanselmei infection in solid organ transplant recipients: report of two cases and review of the literature. Transpl Infect Dis. 2011 Feb; 13(1):73-9.
      View in: PubMed
    12. Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps TJ, Plunkett W, Coombes KR, Abruzzo LV, Keating MJ, Calin GA. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 2010 Aug 12; 116(6):945-52.
      View in: PubMed
    13. Schröppel B, Krüger B, Walsh L, Yeung M, Harris S, Garrison K, Himmelfarb J, Lerner SM, Bromberg JS, Zhang PL, Bonventre JV, Wang Z, Farris AB, Colvin RB, Murphy BT, Vella JP. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol. 2010 Mar; 21(3):536-42.
      View in: PubMed
    14. Alatrash G, Albitar M, O'Brien S, Wang X, Manshouri T, Faderl S, Ferrajoli A, Burger J, Garcia-Manero G, Kantarjian HM, Lerner S, Keating MJ, Wierda WG. Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR). Br J Haematol. 2010 Feb; 148(3):386-93.
      View in: PubMed
    15. Schlette EJ, Admirand J, Wierda W, Abruzzo L, Lin KI, O'Brien S, Lerner S, Keating MJ, Tam C. p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy. Leuk Lymphoma. 2009 Oct; 50(10):1597-605.
      View in: PubMed
    16. Lerner S, Magrane D, Friedman E. Teaching teamwork in medical education. Mt Sinai J Med. 2009 Aug; 76(4):318-29.
      View in: PubMed
    17. Sawinski D, Wyatt CM, Casagrande L, Myoung P, Bijan I, Akalin E, Schröppel B, DeBoccardo G, Sehgal V, Dinavahi R, Lerner S, Ames S, Bromberg J, Huprikar S, Keller M, Murphy B. Factors associated with failure to list HIV-positive kidney transplant candidates. Am J Transplant. 2009 Jun; 9(6):1467-71.
      View in: PubMed
    18. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A. 2009 Mar 3; 106(9):3390-5.
      View in: PubMed
    19. Tsimberidou AM, Tam C, Abruzzo LV, O'Brien S, Wierda WG, Lerner S, Kantarjian HM, Keating MJ. Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia. Cancer. 2009 Jan 15; 115(2):373-80.
      View in: PubMed
    20. Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009 Feb 20; 27(6):904-10.
      View in: PubMed
    21. Lin KI, Tam CS, Keating MJ, Wierda WG, O'Brien S, Lerner S, Coombes KR, Schlette E, Ferrajoli A, Barron LL, Kipps TJ, Rassenti L, Faderl S, Kantarjian H, Abruzzo LV. Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens. Blood. 2009 Apr 2; 113(14):3168-71.
      View in: PubMed
    22. Lerner SM. Kidney and pancreas transplantation in type 1 diabetes mellitus. Mt Sinai J Med. 2008 Aug; 75(4):372-84.
      View in: PubMed
    23. Lerner SM. Review article: the abdominal compartment syndrome. Aliment Pharmacol Ther. 2008 Aug 15; 28(4):377-84.
      View in: PubMed
    24. Tam CS, O'Brien S, Wierda W, Kantarjian H, Wen S, Do KA, Thomas DA, Cortes J, Lerner S, Keating MJ. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood. 2008 Aug 15; 112(4):975-80.
      View in: PubMed
    25. Tam CS, Otero-Palacios J, Abruzzo LV, Jorgensen JL, Ferrajoli A, Wierda WG, Lerner S, O'Brien S, Keating MJ. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients. Br J Haematol. 2008 Apr; 141(1):36-40.
      View in: PubMed
    26. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schröppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1160-7.
      View in: PubMed
    27. Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol. 2008 Jan 10; 26(2):196-203.
      View in: PubMed
    28. Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ, Keating MJ. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. J Clin Oncol. 2007 Oct 10; 25(29):4648-56.
      View in: PubMed
    29. Tam CS, O'Brien S, Lerner S, Khouri I, Ferrajoli A, Faderl S, Browning M, Tsimberidou AM, Kantarjian H, Wierda WG. The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy. Leuk Lymphoma. 2007 Oct; 48(10):1931-9.
      View in: PubMed
    30. Blackall GF, Melnick SA, Shoop GH, George J, Lerner SM, Wilson PK, Pees RC, Kreher M. Professionalism in medical education: the development and validation of a survey instrument to assess attitudes toward professionalism. Med Teach. 2007 Mar; 29(2-3):e58-62.
      View in: PubMed
    31. Borthakur G, O'Brien S, Wierda WG, Thomas DA, Cortes JE, Giles FJ, Kantarjian HM, Lerner S, Keating MJ. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. Br J Haematol. 2007 Mar; 136(6):800-5.
      View in: PubMed
    32. Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Cortes J, Thomas D, Garcia-Manero G, Koller C, Beran M, Giles F, Ravandi F, Lerner S, Kantarjian H, Keating M. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007 Jun 1; 109(11):4679-85.
      View in: PubMed
    33. Uva P, Arvelakis A, Rodriguez-Laiz G, Lerner S, Emre S, Gondolesi G. Common hepatic artery arising from the left gastric artery: a rare anatomic variation identified on a cadaveric liver donor. Surg Radiol Anat. 2007 Feb; 29(1):93-5.
      View in: PubMed
    34. Tsimberidou AM, O'Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, Lerner S, Bueso-Ramos CE, Keating MJ. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. Cancer. 2006 Sep 15; 107(6):1294-302.
      View in: PubMed
    35. Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, Keating MJ. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer. 2006 Jul 1; 107(1):125-35.
      View in: PubMed
    36. Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, Keating MJ. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J Clin Oncol. 2006 May 20; 24(15):2343-51.
      View in: PubMed
    37. Wierda W, O'brien S, Faderl S, Ferrajoli A, Wang X, Do KA, Garcia-Manero G, Thomas D, Cortes J, Ravandi-Kashani F, Giles F, Lerner S, Kantarjian H, Keating M. A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens. Cancer. 2006 Jan 15; 106(2):337-45.
      View in: PubMed
    38. Ravandi F, O'Brien S, Jones D, Lerner S, Faderl S, Ferrajoli A, Wierda W, Garcia-Manero G, Thomas D, Koller C, Verstovsek S, Giles F, Cortes J, Herling M, Kantarjian H, Keating M. T-cell prolymphocytic leukemia: a single-institution experience. Clin Lymphoma Myeloma. 2005 Nov; 6(3):234-9.
      View in: PubMed
    39. Momen A, Bower D, Leuenberger UA, Boehmer J, Lerner S, Alfrey EJ, Handly B, Sinoway LI. Renal vascular response to static handgrip exercise: sympathetic vs. autoregulatory control. Am J Physiol Heart Circ Physiol. 2005 Oct; 289(4):H1770-6.
      View in: PubMed
    40. Pagano CR, Dawson L, Dick A, Lerner SM, Valenia T, Braun J, Smith MA, Farrell C, Alfrey EJ. No increase in rejection or graft loss in kidney transplant recipients with thrombophilia treated with anticoagulation and triple immunosuppression. Transplant Proc. 2005 May; 37(4):1902-4.
      View in: PubMed
    41. Wierda W, O'Brien S, Wen S, Faderl S, Garcia-Manero G, Thomas D, Do KA, Cortes J, Koller C, Beran M, Ferrajoli A, Giles F, Lerner S, Albitar M, Kantarjian H, Keating M. Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia. J Clin Oncol. 2005 Jun 20; 23(18):4070-8.
      View in: PubMed
    42. Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, Andreeff M, Cortes J, Faderl S, Thomas D, Koller C, Wierda W, Detry MA, Lynn A, Kantarjian H. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol. 2005 Jun 20; 23(18):4079-88.
      View in: PubMed
    43. Dick AA, Lerner SM, Boissy AR, Farrell CE, Alfrey EJ. Excellent outcome in infants and small children with thrombophilias undergoing kidney transplantation. Pediatr Transplant. 2005 Feb; 9(1):39-42.
      View in: PubMed
    44. Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW. Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg. 2004 Aug; 139(8):818-21; discussion 821-3.
      View in: PubMed
    45. Tsimberidou AM, Keating MJ, Giles FJ, Wierda WG, Ferrajoli A, Lerner S, Beran M, Andreeff M, Kantarjian HM, O'Brien S. Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia. Cancer. 2004 Jun 15; 100(12):2583-91.
      View in: PubMed
    46. Alfrey EJ, Boissy AR, Lerner SM. Dual-kidney transplants: long-term results. Transplantation. 2003 Apr 27; 75(8):1232-6.
      View in: PubMed
    47. Wierda WG, Johnson MM, Do KA, Manshouri T, Dey A, O'Brien S, Giles FJ, Kantarjian H, Thomas D, Faderl S, Lerner S, Keating M, Albitar M. Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia. Br J Haematol. 2003 Feb; 120(3):452-6.
      View in: PubMed
    48. Yersiz H, Renz JF, Hisatake G, Reichert PR, Feduska NJ, Lerner S, Farmer DG, Ghobrial RM, Geevarghese S, Baquerizo A, Chen P, Busuttil RW. Technical and logistical considerations of in situ split-liver transplantation for two adults: Part II. Creation of left segment I-IV and right segment V-VIII grafts. Liver Transpl. 2002 Jan; 8(1):78-81.
      View in: PubMed
    49. Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, Gornbein J, Yersiz H, Morrissey M, Lerner SM, McDiarmid SV, Busuttil RW. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation. 2001 Sep 27; 72(6):1113-22.
      View in: PubMed
    50. Trani JL, Song HK, Lerner SM, Markmann JW, Barker CF, Naji A, Markmann JF. Comparison of activation requirements and activation phenotype of allogeneic and xenogeneic rodent responses in vivo and in vitro. Transplantation. 2001 Aug 15; 72(3):485-91.
      View in: PubMed
    51. Alfrey EJ, Lerner SM, Lu AD. The dual kidney transplant registry. Clin Transpl. 2001; 107-11.
      View in: PubMed
    52. Gee W, Lerner SM. Invasive blood pressure measurement. S Afr Med J. 1991 Aug 3; 80(3):160-1.
      View in: PubMed
    53. Gee W, Kaupp HA, McDonald KM, Goodreau JJ, Lerner SM. The collateral hemispheric systolic pressure. Arch Surg. 1983 Aug; 118(8):908-12.
      View in: PubMed
    54. Portnoi VF, Dvortsin GF, Machulin AV, Lerner SM, Liakhovich IuS. [Perfusate for cardioplegia on the basis of blood]. Vestn Akad Med Nauk SSSR. 1981; (10):23-31.
      View in: PubMed
    55. Hamilton LW, Timmons CR, Lerner SM. Caloric consequences of sugar solutions: a failure to obtain gustatory learning. Am J Psychol. 1980 Sep; 93(3):387-407.
      View in: PubMed
    56. Lerner SM, Gutterman P, Jenkins F. Epidural hematoma and paraplegia after numerous lumbar punctures. Anesthesiology. 1973 Nov; 39(5):550-1.
      View in: PubMed
    57. Lerner SM. Suppression of a demand pacemaker by transurethral electrocautery. Anesth Analg. 1973 Sep-Oct; 52(5):703-6.
      View in: PubMed
    58. Lerner SM, Hehre FW, Toole AL. Anesthesiology grand rounds Yale-New Haven Hospital. The carcinoid syndrome. Conn Med. 1971 Sep; 35(9):580 passim.
      View in: PubMed
    59. Lerner SM, Hehre FW. Anesthesiology grand rounds Yale-New Haven Hospital. Carotid endareterectomy. Conn Med. 1971 Jul; 35(7):461-4.
      View in: PubMed
    60. Lerner SM, Hehre FW, Moench JC, Guaraldo J. Anesthesiology grand rounds. Yale-New Haven Hospital. Myasthenia gravis. Conn Med. 1971 May; 35(5):336-8.
      View in: PubMed
    61. Lerner SM, Hehre FW, Goldstein J, Harris BR. Anesthesiology grand rounds Yale-New Haven Hospital. Myocardial infarction in surgical patients. Conn Med. 1971 Mar; 35(3):213-5.
      View in: PubMed
    62. Lerner SM, Kirchner JA, Hehre FW. Bilateral abductor paralysis. Conn Med. 1970 Aug; 34(8):580-2.
      View in: PubMed
    63. Lerner SM, Toole AL, Hehre FW. Anesthesiology Grand Rounds, Yale-New Haven Hospital. Hypothermia for excision of hepatic artery aneurysm. Conn Med. 1970 Jan; 34(1):40-4.
      View in: PubMed
    64. Lerner SM, Balmaseda RY, Greenberg RA, Hehre FW. Anesthetic considerations for complicated obstetrics. II. Preeclampsia and hypertensive vascular disease. Anesth Analg. 1969 Sep-Oct; 48(5):771-6.
      View in: PubMed
    Lerner's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067